Delivery Order SPE2DB24D2101-SPE2DB25FKHDW

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,373.82 firm-fixed-price delivery order is for the supply of APREPITANT 40 MG CAPSULE UDS medical products. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Aprepitant 80 mg capsules. The $3,354.88 firm fixed price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,163.40 firm fixed-price delivery order is for the supply of the medication Aprepitant 125-80-80 mg pack. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, awarded by the Defense Logistics Agency (DLA), is for the provision of 4564445711 - APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $3,954.22 and has an ultimate completion date of May 1, 2024. This...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6PDN, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,186.78 firm fixed-price Delivery Order is for the supply of 4564978529 APREPITANT 80 MG CAPSULE UD 6S. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract, valued at up to $18,539.00, is a Delivery Order for the supply of Aprepitant 80 mg capsules. The contract has a period of performance ending on April 23, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,368.44 firm fixed price delivery order is for the supply of 40 mg Aprepitant capsules, which are a specialty pharmaceutical product used in medical treatment programs and facilities. AmerisourceBergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC) with DLA...
This federal contract award, valued at $2,205.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which does not have a set-aside designation, is a delivery order for the supply of pharmaceutical products, specifically the drug Fosamax 70 mg Tablet. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, has been awarded a $150,861.81 firm-fixed-price delivery order contract. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the DoD, and is...
This federal contract award, valued at $2,759.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKHDW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,418.82, is for the delivery of FOSAPREPITANT 150 MG VIALS, a pharmaceutical product.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen has a strong track record of federal contract awards, particularly with the DLA and the Department of Justice Federal Bureau of Investigation, for the provision of essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/27/25, 9:54 AM